Roche Holding AG (SWX:ROG)
Switzerland
· Delayed Price · Currency is CHF 269.70
-2.90 (-1.06%)
Jun 13, 2025, 5:31 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
604.32K CHF
Profits / Employee
80.17K CHF
Market Cap
216.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
| Ypsomed Holding AG | 2,644 |
Roche Holding AG News
- 8 hours ago - [Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys™ gene therapy for Duchenne muscular dystrophy in non-ambulatory patients - GlobeNewsWire
- 4 days ago - Health Canada Authorizes PiaSky® (crovalimab for injection) As the First Monthly (Every Four Weeks) Subcutaneous Treatment for People With Paroxysmal Nocturnal Hemoglobinuria (PNH) - Benzinga
- 4 days ago - Access Medical Labs, a Subsidiary of Empresas Aries, Completes Historic Lab Expansion with Roche Diagnostics Systems - GlobeNewsWire
- 5 days ago - $101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche. - GlobeNewsWire
- 5 days ago - Green Steel Industry Report 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche. - GlobeNewsWire
- 6 days ago - Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy - Benzinga
- 9 days ago - Health Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patients - Reuters
- 10 days ago - Roche gets EU nod for Evrysdi's expanded label in spinal muscular atrophy - Seeking Alpha